Zeus Hygia raises $2.5 Mn from NABVENTURES

Zeus Hygia, a research-driven nutraceutical ingredient manufacturer, has raised $2.5 million in its Series A funding from NABVENTURES, the venture capital arm of NABARD. 

The capital will be used to expand global operations, strengthen R&D, and develop first-in-market solutions focused on pain relief, weight management, women’s health, and healthy aging.

Founded in 2018, Zeus Hygia develops patented, clinically validated herbal extracts for pharmaceutical, nutraceutical, and OTC brands. The firm operates on a B2B model, supplying high-efficacy, plant-based active ingredients to wellness-focused businesses across over 15 countries. 

Its product portfolio includes eight proprietary branded ingredients such as BioSOLVE Curcumin, Grantria, and Stadice, with additional SKUs in development.

The Hyderabad-based startup owns nine patents, has over 20 scientific publications, and uses five proprietary platform technologies to deliver natural, safe, and effective products. It is also expanding its footprint in North America with a U.S. unit and increasing presence in Southeast Asia and MENA through strategic collaborations and joint development projects.

Zeus Hygia expects 70% of its revenue to come from international markets over the next three years.